We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.91T
$1.09B 6.27%
2,537,739
+82,572
+3% +$35.3M
NVDA icon
2
NVIDIA
NVDA
$5.04T
$853M 4.9%
7,025,374
+156,004
+2% +$18.4M
AAPL icon
3
Apple
AAPL
$4.79T
$829M 4.76%
3,558,476
+2,513
+0.1% +$561K
GOOGL icon
4
Alphabet (Google) Class A
GOOGL
$4.24T
$526M 3.02%
3,170,923
+116,544
+4% +$19.5M
LLY icon
5
Eli Lilly
LLY
$1.03T
$448M 2.58%
505,899
+20,283
+4% +$18.2M
AMZN icon
6
Amazon
AMZN
$2.63T
$337M 1.94%
1,810,732
+309,656
+21% +$56.5M
UNH icon
7
UnitedHealth
UNH
$395B
$289M 1.66%
494,938
+44,572
+10% +$25.2M
MRK icon
8
Merck
MRK
$315B
$280M 1.61%
2,465,714
+85,249
+4% +$10.1M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.3B
$265M 1.53%
252,525
+51,817
+26% +$57.7M
AMGN icon
10
Amgen
AMGN
$198B
$262M 1.51%
813,096
+202,928
+33% +$66.4M
MA icon
11
Mastercard
MA
$474B
$204M 1.17%
412,880
-313
-0.1% -$146K
TMO icon
12
Thermo Fisher Scientific
TMO
$193B
$203M 1.17%
328,978
-102,680
-24% -$60.8M
V icon
13
Visa
V
$677B
$203M 1.17%
739,018
-92,354
-11% -$25M
AVGO icon
14
Broadcom
AVGO
$1.83T
$192M 1.1%
1,114,383
+172,623
+18% +$27.7M
PG icon
15
Procter & Gamble
PG
$350B
$185M 1.06%
1,069,830
-44,037
-4% -$7.48M
CRM icon
16
Salesforce
CRM
$136B
$178M 1.02%
651,064
+138,730
+27% +$35.5M
GILD icon
17
Gilead Sciences
GILD
$163B
$175M 1.01%
2,088,287
+68,367
+3% +$5.22M
GOOG icon
18
Alphabet (Google) Class C
GOOG
$4.23T
$166M 0.96%
994,338
+42,354
+4% +$7.17M
NOW icon
19
ServiceNow
NOW
$101B
$152M 0.87%
850,630
-155
-0% -$25.5K
TSM icon
20
TSMC
TSM
$2.17T
$150M 0.86%
864,011
+60,916
+8% +$10.4M
AMD icon
21
Advanced Micro Devices
AMD
$894B
$148M 0.85%
902,358
+247,000
+38% +$37.5M
VRTX icon
22
Vertex Pharmaceuticals
VRTX
$121B
$145M 0.83%
311,307
-16,964
-5% -$8.15M
HD icon
23
Home Depot
HD
$335B
$144M 0.83%
354,531
-27,010
-7% -$9.85M
WM icon
24
Waste Management
WM
$94B
$133M 0.76%
638,357
+4,167
+0.7% +$869K
PANW icon
25
Palo Alto Networks
PANW
$271B
$122M 0.7%
714,332
+94,482
+15% +$15.9M

Similar funds

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.